ImmunologybioRxivPreprint
Dual PD-L1/TIGIT blockade induces PNAd+ HEV-like vessels and CD62L+ lymphocyte recruitment, driving rhabdoid tumor rejection
Stéphanie Fitte-Duval, S Silva, Rafael Mena‐Osuna…·Eliane Piaggio
This study shows that combining PD-L1 and TIGIT blockade in a mouse model of rhabdoid tumors leads to tumor regression by promoting immune cell recruitment and vascular changes.
DOI 10.64898/2025.12.15.692132